ArticleCanadian journal of kidney health and disease2020

Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients.

Bhanu Prasad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.